Service: Economic Modeling

In The News Systematic bias in predictions of new drugs’ budget impact: analysis of a sample of recent US drug launches
In The News Utilization and budget impact of tolvaptan in the inpatient setting among patients with heart failure and hyponatremia
In The News Budget Impact Analysis of Long-Acting Injectable Aripiprazole Once-Monthly 400 mg in Bipolar I Disorder
In The News Cost-Effectiveness Analysis of Long-Acting Injectable Aripiprazole Once-Monthly 400 mg in Bipolar I Disorder
In The News Value-Based Payments and Incentives to Improve Care: A Case Study of Patients with Type 2 Diabetes in Medicare Advantage
In The News Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals
In The News Lanreotide reduces hospital costs for metastatic GEP-NETs
In The News A systematic literature review of methods of incorporating mortality in cost effectiveness analyses of lipid-lowering therapies
In The News Measuring the Value of New Drugs: Validity and Reliability of 4 Value Assessment Frameworks in the Oncology Setting